Welcome to LookChem.com Sign In|Join Free

CAS

  • or
5-METHYL-7,8-DIHYDRO[1,3]DIOXOLO[4,5-G]ISOQUINOLINE is a chemical compound with the molecular formula C11H9NO4. It is a derivative of isoquinoline and contains a dioxolane ring. 5-METHYL-7,8-DIHYDRO[1,3]DIOXOLO[4,5-G]ISOQUINOLINE is of interest due to its potential pharmacological properties and is the subject of research for its potential use in pharmaceuticals. Its unique structure and properties make it a promising candidate for the development of new drugs with a range of potential applications.

17104-27-7 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 17104-27-7 Structure
  • Basic information

    1. Product Name: 5-METHYL-7,8-DIHYDRO[1,3]DIOXOLO[4,5-G]ISOQUINOLINE
    2. Synonyms: 5-METHYL-7,8-DIHYDRO[1,3]DIOXOLO[4,5-G]ISOQUINOLINE;AKOS BBS-00006805;AKOS 203-22;7,8-dihydro-5-methyl-1,3-Dioxolo[4,5-g]isoquinoline
    3. CAS NO:17104-27-7
    4. Molecular Formula: C11H11NO2
    5. Molecular Weight: 189.21
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 17104-27-7.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 303.4 °C at 760 mmHg
    3. Flash Point: 112.8 °C
    4. Appearance: /
    5. Density: 1.34 g/cm3
    6. Vapor Pressure: 0.00168mmHg at 25°C
    7. Refractive Index: 1.647
    8. Storage Temp.: N/A
    9. Solubility: N/A
    10. CAS DataBase Reference: 5-METHYL-7,8-DIHYDRO[1,3]DIOXOLO[4,5-G]ISOQUINOLINE(CAS DataBase Reference)
    11. NIST Chemistry Reference: 5-METHYL-7,8-DIHYDRO[1,3]DIOXOLO[4,5-G]ISOQUINOLINE(17104-27-7)
    12. EPA Substance Registry System: 5-METHYL-7,8-DIHYDRO[1,3]DIOXOLO[4,5-G]ISOQUINOLINE(17104-27-7)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 17104-27-7(Hazardous Substances Data)

17104-27-7 Usage

Uses

Used in Pharmaceutical Industry:
5-METHYL-7,8-DIHYDRO[1,3]DIOXOLO[4,5-G]ISOQUINOLINE is used as a pharmaceutical candidate for its potential pharmacological properties. Its unique structure and properties make it a promising compound for the development of new drugs with a range of potential applications.
Used in Drug Development:
5-METHYL-7,8-DIHYDRO[1,3]DIOXOLO[4,5-G]ISOQUINOLINE is used as a starting material for the synthesis of new drugs. Its unique structure and properties allow for the exploration of various chemical modifications and the development of drugs with novel mechanisms of action.
Used in Research and Development:
5-METHYL-7,8-DIHYDRO[1,3]DIOXOLO[4,5-G]ISOQUINOLINE is used as a research compound to study its potential pharmacological properties and effects. Further research is ongoing to explore its potential uses and applications in various therapeutic areas.

Check Digit Verification of cas no

The CAS Registry Mumber 17104-27-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,7,1,0 and 4 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 17104-27:
(7*1)+(6*7)+(5*1)+(4*0)+(3*4)+(2*2)+(1*7)=77
77 % 10 = 7
So 17104-27-7 is a valid CAS Registry Number.
InChI:InChI=1/C11H11NO2/c1-7-9-5-11-10(13-6-14-11)4-8(9)2-3-12-7/h4-5H,2-3,6H2,1H3

17104-27-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-methyl-7,8-dihydro-[1,3]dioxolo[4,5-g]isoquinoline

1.2 Other means of identification

Product number -
Other names 1-methyl-6,7-methylenedioxy-3,4-dihydroisoquinoline

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:17104-27-7 SDS

17104-27-7Relevant articles and documents

Self-assembly of Fluorescent Dehydroberberine Enhances Mitochondria-Dependent Antitumor Efficacy

An, Ruibing,Gu, Zhanni,Sun, Haifeng,Hu, Yuxuan,Yan, Runqi,Ye, Deju,Liu, Hong

, p. 9812 - 9819 (2018)

Selective imaging and inducing mitochondrial dysfunction in tumor cells using mitochondria-targeting probes has become as a promising approach for cancer diagnosis and therapy. Here, we report the design of a fluorescent berberine analog, dehydroberberine (DH-BBR), as a new mitochondria-targeting probe capable of self-assembling into monodisperse organic nanoparticles (DTNPs) upon integration with a lipophilic counter anion, allowing for enhanced fluorescence imaging and treatment of tumors in living mice. X-ray crystallography revealed that the self-assembly process was attributed to a synergy of different molecular interactions, including π–π stacking, O???π interaction and electrostatic interaction between DH-BBR and counter anions. We demonstrated that DTNPs could efficiently enter tumor tissue following intravenous injection and enhance mitochondrial delivery of DH-BBR via an electrostatic interaction driven anion exchange process. Selective accumulation in the mitochondria capable of emitting strong fluorescence and causing mitochondrial dysfunction was achieved, enabling efficient inhibition of tumor growth in living mice. This study demonstrates promise for applying lipophilic anions to control molecular self-assembly and tune antitumor activity of mitochondria-targeting probes, which can facilitate to improve cancer treatment in vivo.

Structural optimization of berberine as a synergist to restore antifungal activity of fluconazole against drug-resistant Candida albicans

Liu, Hong,Wang, Liang,Li, Yan,Liu, Jiang,An, Maomao,Zhu, Shaolong,Cao, Yongbing,Jiang, Zhihui,Zhao, Mingzhu,Cai, Zhan,Dai, Li,Ni, Tingjunhong,Liu, Wei,Chen, Simin,Wei, Changqing,Zang, Chengxu,Tian, Shujuan,Yang, Jingyu,Wu, Chunfu,Zhang, Dazhi,Liu, Hua,Jiang, Yuanying

supporting information, p. 207 - 216 (2014/01/17)

We have conducted systematic structural modification, deconstruction, and reconstruction of the berberine core with the aim of lowering its cytotoxicity, investigating its pharmacophore, and ultimately, seeking novel synergistic agents to restore the effectiveness of fluconazole against fluconazole-resistant Candida albicans. A structure-activity relationship study of 95 analogues led us to identify the novel scaffold of N-(2-(benzo[d][1,3]dioxol-5-yl)ethyl)-2- (substituted phenyl)acetamides 7 a-l, which exhibited remarkable levels of in vitro synergistic antifungal activity. Compound 7 d (N-(2-(benzo[d][1,3]dioxol- 5-yl)ethyl)-2-(2-fluorophenyl)acetamide) significantly decreased the MIC 80 values of fluconazole from 128.0 μg mL-1 to 0.5 μg mL-1 against fluconazole-resistant C. albicans and exhibited much lower levels of cytotoxicity than berberine toward human umbilical vein endothelial cells. Build it better: Structural optimization of berberine led to the identification of the novel scaffold of N-(2-(benzo[d][1,3]dioxol-5-yl) ethyl)-2-(substituted phenyl)acetamides 7 a-l, which exhibited remarkable in vitro synergistic antifungal activity against fluconazole-resistant Candida albicans in combination with fluconazole. Compound 7 d exhibited much lower cytotoxicity than berberine toward human umbilical vein endothelial cells. Copyright

A very mild access to 3,4-dihydroisoquinolines using triphenyl phosphite-bromine-mediated bischler-napieralski-type cyclization

Vaccari, Daniele,Davoli, Paolo,Ori, Claudia,Spaggiari, Alberto,Prati, Fabio

scheme or table, p. 2807 - 2810 (2009/05/07)

Substituted β-phenylethylamides undergo smooth intramolecular cyclization to 3,4-dihydroisoquinolines in good to excellent yields when treated with bromotriphenoxyphosphonium bromide at -60°C in dichloromethane in the presence of triethylamine. The reaction proceeds under the mildest conditions ever reported for Bischler-Napieralski-type cyclizations. When chlorotriphenoxyphosphonium choride is used, low yields are obtained instead. Georg Thieme Verlag Stuttgart.

Transformation of oximes of phenetyl ketone derivatives to quinolines and azaspirotrienones catalyzed by tetrabutylammonium perrhenate and trifluoromethanesulfonic acid

Kusama,Yamashita,Uchiyama,Narasaka

, p. 965 - 975 (2007/10/03)

Phenethyl ketone oximes are converted to quinolines by the treatment with tetrabutylammonium perrhenate, trifluoromethanesulfonic acid, and chloranil in refluxing 1,2-dichloroethane. Azaspirotrienones can be synthesized from p-hydroxyphenethyl or 3-(p-hydroxyphenyl)propyl ketone oximes by applying the above method. Thus prepared azaspirotrienones are converted to quinolines by acid treatment.

The E.S.R. Spectra of Cation Radicals Derived from Phenethyltetrahydroisoquinoline Ethers and Model Compounds

Hewgill, Frank R.,Pass, Michael C.

, p. 555 - 563 (2007/10/02)

Cation radicals derived from the title compounds by oxidation with thallium tristrifluoroacetate have been characterized.The structures assigned to these radicals suggest that initial oxidation occures at the phenethyl ring in the compounds examined.Oxidation of homolaudanosine in this way gave the expected homoaporphine.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 17104-27-7